Literature DB >> 20213828

Potential role of micro-RNAs in head and neck tumorigenesis.

Nham Tran1, Christopher J O'Brien, Jonathan Clark, Barbara Rose.   

Abstract

A new class of regulatory molecules known as microRNAs (miRNAs) is redefining our understanding of the molecular pathways associated with tumorigenesis. These miRNAs are small noncoding RNA (ncRNA) sequences with potent regulatory potential. The aberrant expression of miRNAs has been associated with the development of various tumors. It has been suggested that miRNAs can both regulate and act as tumor-suppressor genes and oncogenes. Our understanding of the role of miRNAs in head and neck tumorigenesis is in its infancy. However, several recent studies have revealed extensive dysregulation of miRNA in head and neck tumors and have highlighted the potential of certain miRNAs to act as diagnostic and prognostic markers and targets for new therapeutic agents. The intent of this review is to discuss and summarize current findings that point to a significant role for miRNAs in head and neck tumorigenesis. 2010 Wiley Periodicals, Inc. Head Neck, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213828     DOI: 10.1002/hed.21356

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  26 in total

1.  Prognostic value of miR-375 and miR-214-3p in early stage oral squamous cell carcinoma.

Authors:  Angela J Yoon; Shuang Wang; Jing Shen; Nicolas Robine; Elizabeth Philipone; Martin W Oster; Albert Nam; Regina M Santella
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

Review 2.  Emerging biomarkers in head and neck cancer in the era of genomics.

Authors:  Hyunseok Kang; Ana Kiess; Christine H Chung
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

Review 3.  Updated overview of current biomarkers in head and neck carcinoma.

Authors:  Kiran Dahiya; Rakesh Dhankhar
Journal:  World J Methodol       Date:  2016-03-26

4.  Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.

Authors:  Jacob Minor; Xiaotian Wang; Fang Zhang; John Song; Antonio Jimeno; Xiao-Jing Wang; Xian Lu; Neil Gross; Molly Kulesz-Martin; Daren Wang; Shi-Long Lu
Journal:  Oral Oncol       Date:  2011-11-30       Impact factor: 5.337

5.  Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group.

Authors:  Wang-Xia Wang; Natasha Kyprianou; Xiaowei Wang; Peter T Nelson
Journal:  Cancer Res       Date:  2010-09-30       Impact factor: 12.701

6.  MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.

Authors:  Yoshitsugu Mitani; Dianna B Roberts; Hanadi Fatani; Randal S Weber; Merrill S Kies; Scott M Lippman; Adel K El-Naggar
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma.

Authors:  Li-Hsin Chen; Kun-Ling Tsai; Yi-Wei Chen; Cheng-Chia Yu; Kuo-Wei Chang; Shi-Hwa Chiou; Hung-Hai Ku; Pen-Yuan Chu; Ling-Ming Tseng; Pin-I Huang; Wen-Liang Lo
Journal:  J Oncol       Date:  2011-02-15       Impact factor: 4.375

8.  miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma.

Authors:  Nijiro Nohata; Yaeko Sone; Toyoyuki Hanazawa; Miki Fuse; Naoko Kikkawa; Hirofumi Yoshino; Takeshi Chiyomaru; Kazumori Kawakami; Hideki Enokida; Masayuki Nakagawa; Makio Shozu; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2011 Jan-Feb

9.  A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens.

Authors:  Bogumil Kaczkowski; Marya Morevati; Maria Rossing; Finn Cilius; Bodil Norrild
Journal:  Open Virol J       Date:  2012-12-28

Review 10.  MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.

Authors:  Anjie Min; Chao Zhu; Shuping Peng; Saroj Rajthala; Daniela Elena Costea; Dipak Sapkota
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.